Triple
T14117188
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pepto-Bismol |
E339802
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | antidiarrheal drug |
C33469
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: antidiarrheal drug Context triple: [Pepto-Bismol, instanceOf, antidiarrheal drug]
-
A.
histamine H2 receptor antagonist
A histamine H2 receptor antagonist is a drug that selectively blocks histamine H2 receptors on gastric parietal cells, thereby reducing stomach acid secretion and helping to treat conditions like peptic ulcers and gastroesophageal reflux disease.
-
B.
antidote
An antidote is a substance or treatment that counteracts or neutralizes the effects of a poison, toxin, or harmful agent in a living organism.
-
C.
antiseptic agent
An antiseptic agent is a substance applied to living tissue to inhibit or destroy microorganisms and prevent infection without causing significant harm to the host.
-
D.
antimetabolite
An antimetabolite is a drug that mimics natural cellular metabolites to interfere with DNA or RNA synthesis, thereby inhibiting cell growth and division, commonly used in cancer and autoimmune disease treatment.
-
E.
antitubercular agent
An antitubercular agent is a drug used to prevent or treat infections caused by Mycobacterium tuberculosis by inhibiting its growth or killing the bacteria.
- F. None of above. chosen
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c6a95b481909e39111e0c1f31ee |
completed | April 9, 2026, 9:38 p.m. |
Created at: April 9, 2026, 10:22 p.m.